Results 41 to 50 of about 1,107,019 (331)

Clinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center study [PDF]

Intestinal Research, 2022
Background/Aims Very early-onset inflammatory bowel disease (VEO-IBD), defined as IBD diagnosed in patients younger than 6 years, is a challenge for pediatric gastroenterologists.
Masaaki Usami, Ichiro Takeuchi, Reiko Kyodo, Yuri Hirano, Kosuke Kashiwagi, Hiroki Fujikawa, Hirotaka Shimizu, Toshinao Kawai, Katsuhiro Arai   +8 more
doaj   +1 more source

The burden of inflammatory bowel disease in Europe in 2020.

Journal of Crohn's & Colitis, 2021
New data suggest that incidence and prevalence of inflammatory bowel diseases (IBD) are still increasing worldwide, and approximately 0.2% of the European population suffers from IBD at the present time.
Mirabella Zhao, L. Gönczi, P. Lakatos, J. Burisch   +3 more
semanticscholar   +1 more source

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

Genome Biology, 2012
The inflammatory bowel diseases (IBD) Crohn's disease and ulcerative colitis result from alterations in intestinal microbes and the immune system. However, the precise dysfunctions of microbial metabolism in the gastrointestinal microbiome during IBD ...
X. Morgan, Timothy L. Tickle, H. Sokol, D. Gevers, K. Devaney, D. Ward, Joshua A Reyes, Samir A. Shah, N. LeLeiko, S. Snapper, A. Bousvaros, J. Korzenik, B. Sands, R. Xavier, C. Huttenhower   +14 more
semanticscholar   +1 more source

Evaluation of changes in intestinal microbiota in Crohn’s disease patients after anti-TNF alpha treatment

Scientific Reports, 2021
Intestinal dysbiosis is key in the onset and development of Crohn’s disease (CD). We evaluated the microbiota changes in CD patients before and after a six-month anti-TNF treatment, comparing these changes with the microbiota of healthy subjects.
Laura Sanchis-Artero, Juan Francisco Martínez-Blanch, Sergio Manresa-Vera, Ernesto Cortés-Castell, Marina Valls-Gandia, Marisa Iborra, Jose Maria Paredes-Arquiola, Maia Boscá-Watts, Jose Maria Huguet, Rafael Gil-Borrás, Josefa Rodríguez-Morales, Xavier Cortés-Rizo   +11 more
doaj   +1 more source

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2005
The discovery of a series of genetic and serological markers associated with disease susceptibility and phenotype in inflammatory bowel disease has led to the prospect of an integrated classification system involving clinical, serological and genetic ...
M. Silverberg, J. Satsangi, T. Ahmad, I. Arnott, C. Bernstein, S. Brant, R. Caprilli, J. Colombel, C. Gasche, K. Geboes, D. Jewell, Amir S Karban, E. Loftus, A. Peña, R. Riddell, Frcpc FRCPath, D. Sachar, S. Schreiber, A. Steinhart, S. Targan, S. Vermeire, B. Warren   +21 more
semanticscholar   +1 more source

Management of Anal Fistula with Crohn's Disease

Journal of the Anus, Rectum and Colon
Crohn's disease (CD) causes gastrointestinal symptoms (i.e., diarrhea and abdominal pain), systemic symptoms (i.e., fatigue, anemia, weight loss, and fever), and perianal fistulas that produce anal pain. Because of the frequent occurrence of diarrhea and
Shota Takano, Yasushi Nakamura, Kohei Tamaoka, Takafumi Yoshimoto, Yasue Irei, Yoriyuki Tsuji   +5 more
doaj   +1 more source

Enterogenous Microbiotic Markers in the Differential Diagnosis of Crohn’s Disease and Intestinal Tuberculosis

Frontiers in Immunology, 2022
Crohn’s disease (CD) is a chronic intestinal disorder characterized by refractory gastrointestinal ulcerations. Intestinal tuberculosis (ITB) is one common intestinal disease in east Asia.
Mingshan Jiang, Mingshan Jiang, Mingshan Jiang, Zhen Zeng, Zhen Zeng, Zhen Zeng, Kexin Chen, Kexin Chen, Kexin Chen, Yuan Dang, Yuan Dang, Yuan Dang, Lili Li, Lili Li, Lili Li, Chunxiang Ma, Chunxiang Ma, Chunxiang Ma, Rui Cheng, Rui Cheng, Rui Cheng, Kehan Hu, Kehan Hu, Kehan Hu, Xi Li, Xi Li, Xi Li, Hu Zhang, Hu Zhang, Hu Zhang   +29 more
doaj   +1 more source

Inflammatory bowel disease biomarkers

Medicinal research reviews (Print), 2022
Inflammatory bowel disease (IBD) is characterized as chronic inflammation in the gastrointestinal tract, which includes two main subtypes, Crohn's disease and ulcerative colitis.
Dandan Liu, Varma Saikam, Katie A Skrada, D. Merlin, S. Iyer   +4 more
semanticscholar   +1 more source

Prolonged time to treatment of biologics in inflammatory bowel disease: disparities from a retrospective study in a tertiary referral centre in the UK

BMC Gastroenterology
Background Several disparities in healthcare utilisation and delivery are reported in inflammatory bowel disease (IBD). We examined disparities for delays in biologic administration.
Charlotte Wong, Paul Bassett, Nikolaos Kamperidis, Ravi Misra, Lisa Younge, Lovesh Dyall, Katie Yeung, Christy Rejee, Naila Arebi   +8 more
doaj   +1 more source

From omics to AI—mapping the pathogenic pathways in type 2 diabetes

FEBS Letters, EarlyView.
Integrating multi‐omics data with AI‐based modelling (unsupervised and supervised machine learning) identify optimal patient clusters, informing AI‐driven accurate risk stratification. Digital twins simulate individual trajectories in real time, guiding precision medicine by matching patients to targeted therapies.
Siobhán O'Sullivan, Lu Qi, Pierre Zalloua   +2 more
wiley   +1 more source